K.A.R.M.A: Ketamine's Action on Rumination Mechanisms as an Antidepressant
02 October 2016
Ketamine, a widely used anesthetic, has recently emerged as an effective, rapid acting antidepressant with promising effects in treatment resistant depression. Ketamine’s targets in the brain include areas that are involved in rumination processes. The aim of the present study is to identify the brain areas that are modulated by ketamine while ruminating. These brain areas could then be used to help us identify depressed patients who are most likely to respond to ketamine.
Keywords
Ethical approval
This study has been approved by the Psychiatry Nursing and Midwifery Research Ethics Subcommittee, King's College London on June 18th 2015.
About the researcher
My name is Vasileia Kotoula and I am a PhD student at the Department of Neuroimaging, King's College London. Our research team and myself in particular are really grateful for your interest in our study!!
